Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

CMS emphasizes flexibility in webinar on proposed MACRA rule

CMS officials went over the numerous criteria factoring into the two new reporting paths, along with how and when clinicians would be scored under the new system.

Hospitalizations for opioid abuse double, costs quadruple in 10 years

Hospitalizations related to opioid abuse/dependence doubled while inpatient charges almost quadrupled between 2002 and 2012.

New CMS fire safety rule includes sprinkler requirement for high-rise buildings

CMS is updating its fire safety guidelines for the first time in 13 years with several new standards on automatic sprinkler systems, and allowing aerosol alcohol-based hand rub dispensers.

CMS finalizes quality measure plan for MACRA transition

Following the rollout of the final MACRA rule, CMS has released its final framework for its Quality Measure Development Plan (MDP) to support its new reporting paths.

European study says fasting unnecessary for cholesterol tests

Two European medical associations have published a study that argues for non-fasting assessment of plasma lipid profiles.

AMA to educate doctors on value-based care models

The American Medical Association announced a series of online resources for physicians choosing new payment models that emphasize value-based care.

New health startups dealing with increased FDA scrutiny

As more health-related tech startups emerge in Silicon Valley, the FDA and other government agencies are stepping up their presence in the region like never before.

Study: Increased spending on social services improves health

States that increased spending on public health and social services programs between 2000 and 2009 saw significant improvement in health outcomes in areas such as adult obesity and asthma.

Displaying 2617 - 2624 of 3407

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.